ABOUT

Who we are

Our mission is to help improving the outcome of patients suffering (or at risk of suffering) from cardioneurovascular diseases.

Emosis develops and provides physicians with first-in-class, on demand, and user-friendly extended in vitro diagnostic products, centered on lab assay kits to be routinely performed on the rapidly growing new generation of flow cytometers, including highly automated, compact benchtop devices.

These products aim at providing a comprehensive blood test panel for the bioclinical investigation of vascular thrombosis-induced or complicated diseases, in which clots formed in veins or arteries impede or block the blood flow to the heart, lungs, brain or other organs.

These tests whose development is rooted in the unfolding of thrombosis biological complexity, aim at informing physician medical decision making with respect to thrombotic events or risk in a broad range of clinical settings, such as coronary disease, arteritis, deep venous thrombosis, cancer, COVID-19, pregnancy and pharmacological and non-pharmacological therapies.

We are open to the world, with a series of international collaborations and a distribution network with a global reach over more than forty countries, involving 5-Diagnostics, Erba RUS, and ENCO.

Our head office is located in Illkirch-Graffenstaden, France, close to the German and Swiss borders, and we have a subsidiary in Tel Aviv, Israel.